Your browser is no longer supported. Please, upgrade your browser.
JAZZ Jazz Pharmaceuticals plc daily Stock Chart
Jazz Pharmaceuticals plc
Index- P/E14.17 EPS (ttm)10.45 Insider Own2.80% Shs Outstand56.19M Perf Week-1.34%
Market Cap8.32B Forward P/E8.48 EPS next Y17.46 Insider Trans-1.43% Shs Float55.06M Perf Month15.88%
Income608.80M PEG1.67 EPS next Q4.08 Inst Own95.10% Short Float5.32% Perf Quarter17.11%
Sales2.06B P/S4.05 EPS this Y34.60% Inst Trans1.40% Short Ratio5.23 Perf Half Y13.08%
Book/sh53.89 P/B2.75 EPS next Y10.04% ROA11.30% Target Price170.88 Perf Year2.39%
Cash/sh19.04 P/C7.78 EPS next 5Y8.50% ROE21.10% 52W Range113.52 - 153.03 Perf YTD19.47%
Dividend- P/FCF9.51 EPS past 5Y15.80% ROI12.20% 52W High-2.16% Beta1.15
Dividend %- Quick Ratio3.70 Sales past 5Y16.70% Gross Margin94.20% 52W Low31.89% ATR3.39
Employees1360 Current Ratio3.90 Sales Q/Q14.60% Oper. Margin31.90% RSI (14)75.39 Volatility2.21% 2.56%
OptionableYes Debt/Eq0.53 EPS Q/Q-26.20% Profit Margin29.60% Rel Volume0.57 Prev Close148.10
ShortableYes LT Debt/Eq0.51 EarningsNov 05 AMC Payout0.00% Avg Volume559.57K Price149.72
Recom1.90 SMA206.05% SMA5014.54% SMA20012.10% Volume277,589 Change1.09%
Aug-21-19Downgrade Piper Jaffray Overweight → Neutral $205 → $142
Jun-11-19Initiated Barclays Overweight $164
Mar-20-19Initiated SunTrust Buy $163
Dec-14-18Initiated Wolfe Research Peer Perform
Nov-08-18Reiterated B. Riley FBR Buy $219 → $190
Aug-08-18Reiterated Stifel Buy $180 → $205
Jul-11-18Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-23-18Reiterated H.C. Wainwright Neutral $150 → $160
Mar-19-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-03-18Initiated Leerink Partners Outperform $180
Dec-05-17Reiterated Mizuho Neutral $144 → $150
Nov-10-17Resumed H.C. Wainwright Neutral $150
Nov-08-17Reiterated RBC Capital Mkts Outperform $210 → $195
Oct-19-17Initiated FBR & Co. Buy $206
Oct-05-17Initiated Morgan Stanley Equal-Weight $155
Sep-28-17Initiated Goldman Neutral $165
Aug-25-17Initiated H.C. Wainwright Neutral $144
May-31-17Reiterated Mizuho Neutral $150 → $144
May-15-17Initiated RBC Capital Mkts Outperform $210
Apr-06-17Downgrade Mizuho Buy → Neutral $162 → $150
Dec-06-19 11:46AM  Hedge Funds Got Back Into Jazz Pharmaceuticals plc (JAZZ) At The Right Time Insider Monkey
Dec-05-19 11:31AM  Jazz (JAZZ) Up 16.4% Since Last Earnings Report: Can It Continue? Zacks
08:02AM  5 Discounted PEG Stocks for GARP Investors Zacks
Dec-04-19 08:20AM  Axsome Narcolepsy Candidate Meets Phase II Goal, Stock Up Zacks
Dec-03-19 04:13PM  Why This IBD 50 Stock Stumbled After Its Rival Posted A 15% Gain Investor's Business Daily
12:45PM  3 Reasons Growth Investors Will Love Jazz (JAZZ) Zacks
Dec-02-19 09:32AM  Bullish Looking Jazz Pharmaceutical Gets a Boost From a Quant Buy Recommendation
09:17AM featured highlights include: Jazz Pharmaceuticals, Mr. Cooper Group, Sonic Automotive, Hibbett Sports and Jones Lang LaSalle Zacks
08:38AM  Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 9.8% Zacks
Nov-29-19 09:39AM  Catalyst Focuses on Firdapse Label Expansion Amid Competition Zacks
07:45AM  Buy These 5 Top-Ranked Stocks With Relative Price Strength Zacks
Nov-27-19 09:30AM  JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Nov-26-19 09:10AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
Nov-25-19 05:08PM  Zoetis (ZTS) Acquires ZNLabs to Bolster Diagnostics Portfolio Zacks
08:56AM  Jazz Pharmaceuticals plc (JAZZ) Shares March Higher, Can It Continue? Zacks
Nov-22-19 08:48AM  Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session Zacks
Nov-21-19 03:20PM  Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA Zacks
09:43AM  Edited Transcript of JAZZ earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-19-19 07:50AM  Is Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) CEO Paid At A Competitive Rate? Simply Wall St.
Nov-18-19 05:34PM  Rigel Gets Positive CHMP Review for Thrombocytopenia Drug Zacks
10:17AM  Medtronic (MDT) to Report Q2 Earnings: What's in Store? Zacks
09:02AM  Jazz Pharmaceuticals, Canon, Advanced Energy Industries, Inphi and Skyworks Solutions highlighted as Zacks Bull and Bear of the Day Zacks
09:01AM  Jazz's (JAZZ) Sleep Drug Sunosi Nears Approval in Europe Zacks
07:00AM  Bull of the Day: Jazz Pharma (JAZZ) Zacks
Nov-15-19 10:20AM  Why Jazz (JAZZ) Might be Well Poised for a Surge Zacks
09:08AM  New Strong Buy Stocks for November 15th Zacks
07:04AM  Jazz Pharma's sleep disorder drug gets European panel backing Reuters
06:45AM  Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea PR Newswire
Nov-14-19 04:05PM  Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences PR Newswire
Nov-12-19 09:03AM featured highlights include: Lithia, KB, Anixter, Navient and Jazz Zacks
Nov-11-19 09:30AM  JAZZ or ZTS: Which Is the Better Value Stock Right Now? Zacks
08:45AM  Here is Why Growth Investors Should Buy Jazz (JAZZ) Now Zacks
08:34AM  Bet on These 5 High Earnings Yield Stocks to Book Profits Zacks
Nov-07-19 09:10AM  Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now? Zacks
08:00AM  Jazz Pharmaceuticals to Highlight Growing Hematology Oncology Pipeline at ASH 2019 Annual Meeting PR Newswire
Nov-06-19 10:36AM  Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales Zacks
Nov-05-19 06:25PM  Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Surpass Estimates Zacks
04:05PM  Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results PR Newswire
09:29AM  Stocks That Would Have Made You Rich Today GOBankingRates
Nov-04-19 11:54AM  ImmunoGen (IMGN) Q3 Earnings & Sales Beat, Shares Rally Zacks
11:38AM  What's in the Cards for Teva (TEVA) This Earnings Season? Zacks
11:23AM  Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More Zacks
Nov-01-19 11:07AM  WIll Allergan (AGN) Beat Estimates This Earnings Season? Zacks
11:05AM  Is a Beat in the Cards for Mallinckrodt (MNK) in Q3 Earnings? Zacks
10:42AM  Is a Beat in the Cards for Regeneron (REGN) Q3 Earnings? Zacks
09:15AM  Bristol-Myers (BMY) Hits Fresh High: Is There Still Room to Run? Zacks
Oct-30-19 12:44PM  Guardant Health (GH) to Report Q3 Earnings: What's in Store? Zacks
09:15AM  Small Step Back Ahead of Fed, Apple Zacks
Oct-29-19 10:33AM  Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth Zacks
09:46AM  Catalyst Pharma (CPRX) to Post Q3 Earnings: What's in Store? Zacks
Oct-28-19 10:43AM featured highlights include: Koppers, Alaska Air, Guess?, Lionsgate and Jazz Pharmaceuticals Zacks
Oct-25-19 09:16AM  Invest in These 5 High Earnings Yield Stocks Right Away Zacks
Oct-24-19 10:50AM  5 Drug/Biotech Stocks Likely to Surpass on Earnings in Q3 Zacks
10:39AM  Baxter (BAX) Misses Q3 Revenue Estimates, Issues Guidance Zacks
10:10AM  Why the Earnings Surprise Streak Could Continue for Jazz (JAZZ) Zacks
09:30AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
Oct-22-19 04:05PM  Jazz Pharmaceuticals to Report 2019 Third Quarter Financial Results on November 5, 2019 PR Newswire
Oct-14-19 06:38PM  Hedge Funds Are Selling Jazz Pharmaceuticals Public Limited Company (JAZZ) Insider Monkey
09:15AM  Zoetis (ZTS) Soars to 52-Week High, Time to Cash Out? Zacks
Oct-11-19 12:49PM  Jazz Starts CAR T-cell Linked Neurotoxicity Study Enrollment Zacks
Oct-10-19 04:15PM  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity PR Newswire
09:51AM  5 High Earnings Yield Stocks to Buy for a Rewarding Portfolio Zacks
Oct-09-19 08:52AM  Jazz Pharmaceuticals Enters Oversold Territory Zacks
Oct-08-19 09:30AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks -5.58%
Oct-03-19 03:49PM  Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar Benzinga
Sep-30-19 08:30AM  Jazz Pharmaceuticals Survey Highlights Prevalence of Misinformation and Misperception About Narcolepsy Among Americans PR Newswire
Sep-26-19 07:54AM  The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J Benzinga
Sep-25-19 08:00PM  Jazz Pharmaceuticals Presents Positive JZP-258 Phase 3 Study Data at World Sleep 2019 PR Newswire
Sep-24-19 09:10AM  Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now? Zacks
Sep-20-19 04:43PM  Biotechs Fly Sideways In Quiet Week 5 News Items You May Have Missed Investor's Business Daily
09:23AM  Jazz Pharmaceuticals Has Good News on Narcolepsy Drug, Analyst Says
Sep-18-19 04:05PM  Jazz Pharmaceuticals Announces Webcast for World Sleep Congress Investor Update PR Newswire
Sep-07-19 10:36AM  Here's Why I Think Jazz Pharmaceuticals (NASDAQ:JAZZ) Is An Interesting Stock Simply Wall St.
Sep-06-19 09:40AM  JAZZ vs. CTLT: Which Stock Is the Better Value Option? Zacks
09:10AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
07:52AM  Jazz Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy? Zacks
07:27AM  The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication Benzinga
Sep-05-19 06:44PM  Edited Transcript of JAZZ earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
09:31AM  Jazz (JAZZ) Down 7.4% Since Last Earnings Report: Can It Rebound? Zacks
Aug-27-19 04:05PM  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences PR Newswire
02:51PM  5 GARP Stocks To Buy Today InvestorPlace
Aug-20-19 07:04AM  Is Jazz Pharmaceuticals (NASDAQ:JAZZ) A Risky Investment? Simply Wall St.
Aug-14-19 09:40AM  Is Jazz Pharmaceuticals (JAZZ) a Profitable Value Stock? Zacks
Aug-13-19 12:59PM  Jazz buys Virginia biotech firm in deal valued at up to $312.5M American City Business Journals
11:12AM  Jazz (JAZZ) Acquires Cavion, Adds Movement Disorder Candidate Zacks
07:25AM  The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results Benzinga
Aug-12-19 04:01PM  Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc. PR Newswire
Aug-09-19 03:24AM  (PFNX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 11:20AM  Jazz Pharma (JAZZ) Q2 Earnings and Sales Beat Estimates Zacks
06:30AM  Jazz Pharmaceuticals Sings a Sweet Tune in Q2 Motley Fool
05:24AM  Jazz Pharmaceuticals (JAZZ) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 07:15PM  Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates Zacks
04:05PM  Jazz Pharmaceuticals Announces Second Quarter 2019 Financial Results PR Newswire
04:01PM  Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program PR Newswire
Aug-02-19 09:06AM  What's in the Cards for Bausch Health (BHC) in Q2 Earnings? Zacks
08:44AM  Is a Beat in the Cards for Regeneron (REGN) Q2 Earnings? Zacks
Jul-31-19 09:27AM  Is There An Opportunity With Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) 34% Undervaluation? Simply Wall St.
Jul-30-19 10:38AM  Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy? Zacks
Jul-25-19 09:20AM  Jazz (Pharmaceuticals) Has Pizzazz With Quant Upgrade and Bullish Charts
Jul-24-19 10:10AM  Will Jazz (JAZZ) Beat Estimates Again in Its Next Earnings Report? Zacks
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adult and pediatric patients with narcolepsy; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease, a potentially life-threatening complication of hematopoietic stem cell transplantation; and Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia. The company also develops Solriamfetol for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea, as well as in Phase II clinical trial for EDS associated with Parkinson's disease; Vyxeos for acute myeloid leukemia; and JZP-258 to treat EDS and cataplexy with narcolepsy and potential treatment of idiopathic hypersomnia and a chronic neurological disorder. In addition, it sells psychiatry and other products. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; and XL-protein GmbH. The company is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COZADD BRUCE CChairman & CEODec 02Sale150.0010,7501,612,500301,138Dec 04 05:51 PM
COZADD BRUCE CChairman & CEONov 05Sale130.0050065,000311,855Nov 07 06:53 PM
COZADD BRUCE CChairman & CEOOct 01Sale130.0050065,000312,355Oct 03 05:03 PM
Treacy PaulSVP, Technical OperationsAug 12Sale137.404,371600,58916,418Aug 14 05:33 PM
ENRIGHT PATRICK GDirectorAug 09Sale135.6572698,48117,663Aug 12 05:50 PM
Winningham Rick EDirectorAug 09Sale135.6572698,4824,424Aug 12 05:48 PM
Sohn Catherine A.DirectorAug 09Sale135.6572698,4828,848Aug 12 05:38 PM
Schnee ElmarDirectorAug 09Sale135.65817110,8257,197Aug 12 05:36 PM
RIEDEL NORBERT GDirectorAug 09Sale135.6572698,4827,685Aug 12 05:32 PM
O'Keefe Kenneth WDirectorAug 09Sale135.6572698,4825,644Aug 12 05:29 PM
McSharry Heather AnnDirectorAug 09Sale135.65787106,7568,637Aug 12 05:26 PM
Gray PeterDirectorAug 09Sale135.65787106,7579,315Aug 12 05:23 PM
BERNS PAUL LDirectorAug 09Sale135.6572698,4817,966Aug 12 05:07 PM
Treacy PaulSVP, Technical OperationsMar 06Sale135.411,060143,53520,649Mar 07 07:18 PM
Young Matthew P.EVP & CFOMar 06Sale135.411,152155,99236,200Mar 07 07:13 PM
Treacy PaulSVP, Technical OperationsMar 01Sale139.50874121,92321,709Mar 04 07:41 PM
Hooper Suzanne SawochkaEVP & General CounselFeb 27Option Exercise46.836,666312,16946,404Feb 27 09:10 PM
Hooper Suzanne SawochkaEVP & General CounselFeb 27Sale140.006,666933,24039,738Feb 27 09:10 PM
Young Matthew P.EVP & CFOFeb 27Sale137.91884121,91227,967Feb 27 08:38 PM
Young Matthew P.EVP & CFOFeb 26Sale125.931,032129,96029,885Feb 27 08:38 PM
Hooper Suzanne SawochkaEVP & General CounselDec 14Option Exercise46.833,295154,30544,518Dec 14 06:04 PM
Hooper Suzanne SawochkaEVP & General CounselDec 14Sale140.213,334467,46041,184Dec 14 06:04 PM